Article -> Article Details

Acknowledging the exponential growth records, the market is posting continually, Market Research Future (MRFR), in its recently published analysis report asserts that the global Appendicitis market will witness significant accruals by 2023 registering 4.2% CAGR throughout the forecast period (2017 – 2023). The improving economic conditions worldwide, define the growth that the appendicitis market perceives today, enabling access to the quality of life & to the improved healthcare.

Technological advancement transpired into medical science is a key driving force pushing up the growth of the market bringing about advanced diagnostic and treatment procedures. Moreover, the increasing emphasis on early diagnosis of the disease defines the market landscape.  Furthermore, the increasing occurrences of appendicitis along with the rising demand for diagnostic and treatment options of appendicitis support the market growth.

On the flip side, factors such as the unmet medical needs and drug resistance restrict market growth, up to some extent. Nevertheless, technological advancements expected to take place soon are expected to support market growth throughout the forecast period, advancing medical devices.

Appendicitis Market – Regional Analysis

The appendicitis market in the European region holds the next largest share in the global market, owing to the resurging economy that is availing the best possible healthcare and increasing the healthcare expenditures. Germany, France, and the U.K backed by the increasing demand for the technological advanced diagnostic devices account for the major contributors to the Europe appendicitis market.

The well-developed healthcare sector and the notable pharmaceutical companies that are engaged in R&D activities for the development of new drugs to treat appendicitis are some of the key driving forces behind the growth of the regional market. Additionally, government support is fostering the market growth in the region, encouraging the market players to develop effective therapeutics.

Whereas, the Asia Pacific appendicitis market is growing rapidly, emerging as a promising market, globally owing to the introduction of new & advanced diagnostic options such as CT scan. The rising demand for specialty healthcare services in emerging countries such as India has fuelled the growth of the regional market.

Also, factors such as the ever-increasing population and the integration of advanced technologies in the healthcare sector are propelling the growth of the regional market. Asian countries especially, India and China provide immense growth opportunities for the appendicitis market, accounting for the considerable investment in R&D activities for prognostic treatments and drug formulation.

Global Appendicitis Market   – Competitive Analysis

Highly competitive, the appendicitis market appears to be widely expanded and fragmented characterized by several small and large-scale companies operating the market. Matured players incorporate strategic initiatives such as partnership, acquisition, collaboration, product launch, and expansion, gaining a competitive advantage and thus maintaining their positions in this market.

These players ensure their mission success, focusing on optimizing situational awareness towards customers. They invest substantially in the R&D and clinical trials to develop breakthrough treatment procedures and drugs. To maximize their efficiency in the process and operations, key players are focusing on developing a bettered method, a diagnostic and treatment-response of the disease.

Industry/Innovation/ Related News:

January 15, 2019 — A group of scientists from the different universities of Izmir, Turkey including Department of Pediatric Surgery, Izmir Katip Celebi University, and Department of Microbiology, Ataturk Education & Research Hospital, Turkey, published their study on Pentraxin-3, a strong novel biochemical marker for appendicitis in children in the American Journal of Emergency Medicine.

Researchers investigated the diagnostic values of pentraxin-3/PTX-3 in pediatric appendicitis and compared it with the other serum parameters.

In this study, these researchers have shown that PTX-3 is very useful with high specificity and sensitivity in the diagnosis of appendicitis compared to ANS, WBC, NLR, and CRP as a first in the literature.